TrialEuropean journal of clinical investigation2022

Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments?

Qidi Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.